Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report)’s share price rose 4.5% during mid-day trading on Wednesday . The stock traded as high as $4.39 and last traded at $4.38. Approximately 163,361 shares were traded during mid-day trading, an increase of 5% from the average daily volume of 156,314 shares. The stock had previously closed at $4.19.
Analysts Set New Price Targets
BIOX has been the subject of several recent research reports. Canaccord Genuity Group dropped their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a report on Thursday, February 13th. Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research note on Friday, February 7th. Finally, Oppenheimer reduced their price objective on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $9.88.
Check Out Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Stock Performance
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Fourth Sail Capital LP increased its stake in Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after purchasing an additional 527,859 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Bioceres Crop Solutions by 135.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock valued at $4,574,000 after buying an additional 432,206 shares during the period. Long Focus Capital Management LLC increased its position in shares of Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after buying an additional 421,931 shares in the last quarter. Ballast Asset Management LP raised its stake in Bioceres Crop Solutions by 23.5% during the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after buying an additional 82,187 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Insider Trades May Not Tell You What You Think
- Energy Transfer: Powering Data With Dividends and Diversification
- Business Services Stocks Investing
- Qualcomm Stock Is Coiling for a Breakout
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.